SCOTTSDALE, Ariz., April 11, 2006 (PRIMEZONE) -- Desert Health Products, Inc. (OTCBB:DHPI) announces it has received authorization to market internationally: OXINE(R) a 100% bio-degradable patented product and bio-security agent against avian influenza. OXINE(R) is manufactured by Bio-Cide International, Inc., a producer of environmentally friendly products, headquartered in Norman, Oklahoma USA.
OXINE(R) provides superior sanitation in the following areas of applications: Misting and Water Treatment for Laying and Hatchery Environs. For Breeders and Broiler Houses: Eliminates Bio-Film; Walls, Floors, Ceilings & Drains. Additional usage for any Hard Surface Disinfections and Animal Hospital applications.
OXINE(R) fed through the watering system and misted over poultry has shown effective results against Avian Influenza, Salmonella, Coccidiosis and E. Coli.
OXINE's(R) patented chemistry allows the product to be suspended in water and most importantly, to be stable. The product is 100% biodegradable and leaves no residue.
OXINE(R) is a chlorine dioxide gas suspended and stabilized in an aqueous solution. It can be used as a disinfecting fog and as a special mist to control surface contaminants and eliminate airborne disease causing microbes. Applications are fully registered with EPA, USDA and FDA.
David Stewart, President and CEO of Desert Health, "We anticipate nearly immediate worldwide interest in this product as its application addresses one of the primary concerns of our planet today."
Desert Health Products Inc. is an international distributor of a unique line of health related products and a proprietary blend of nutrition and dietary supplements. DHPI has implemented a global commercialization strategy for its diversified line of nutritional products and is expanding its line to include several exclusive new applications that can potentially address significant health problems worldwide.
Safe Harbor Statement: This release contains statements that are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current estimates and projections about Desert Health Products, Inc.'s business, which are derived in part on assumptions of its management, and are not guarantees of Desert Health Products, Inc.'s future performance, as such performance is difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Such factors include, but are not limited to, those described in Desert Health Products, Inc.'s Annual Report on Form 10-KSB for the year ended December 31, 2004, and its Quarterly Report on Form 10-QSB for the three-month period ended September 30, 2005, which are filed with the U.S. Securities and Exchange Commission. Readers of this release are referred to those filings. Desert Health Products, Inc., does not intend to update any of these forward-looking statements after the date of this release.